MedTrace Logo

Mixed Methods Evaluation of the Pomona Household Universal Grant (HUG) Program

NCT06505811 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2026-05-11

No results posted yet for this study

Summary

The City of Pomona is launching the Pomona Household Universal Grant (HUG) program in the Summer of 2024. Pomona HUG is a pilot project that will provide 250 parents/caregivers with children under 5 years old $500 a month for 18 months. Pomona's guaranteed income (GI) initiative provides relief for the most economically vulnerable households. The study will investigate the impacts of GI on financial security, material hardship, health and well-being, food security, social support, parenting, and childhood development. The intervention group will be compared to a control group of 350 parents/caregivers receiving only a nominal ($20) amount per month during the 18 month period.

Conditions

  • Early Child Well-being
  • Parental Stress
  • Family Economic Security
  • Parental/Caregiver Health
  • Mental Health

Interventions

BEHAVIORAL

Guaranteed Income ($500/monthly)

Participants receive $500 monthly for up to 18 months.

BEHAVIORAL

Active Comparison ($20/monthly)

Participants receive $20 monthly for up to 18 months.

Sponsors & Collaborators

Principal Investigators

  • Judith L Perrigo, PhD · University of California, Los Angeles

  • Daniel Eisenberg, PhD · University of California, Los Angeles

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-17
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06505811 on ClinicalTrials.gov